Evidence map›Paper›PMID 38164143›Full record

ArticleTheranostics2024

Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation.

Xiaoyao Zhang, Li Li, Huishi Tan, Xue Hong, Qian Yuan, Fan Fan Hou, Lili Zhou, Youhua Liu

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Renal IGFBP6 Interacts With THBS1 to Drive Renal Cellular Senescence and Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. [Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Xiaoyao ZhangDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Li LiDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Huishi TanDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xue HongDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Qian YuanDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Fan Fan HouDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Lili ZhouDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Youhua LiuDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Nanfang Hospital · CN

Funding

Key Technologies R&D Program of Guangdong Province 2023B1111030004National Key Research and Development Program of China 2022YFC2502504National Natural Science Foundation of China 81920108007 AND 82230020,
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MicroRNAsRenal Insufficiency, ChronicRNA, Long NoncodingAnimalsCellular SenescenceKidneyMicePeptidesMicroRNAsPeptidesRNA, Long Noncodingcellular senescencechronic kidney diseasekidney fibrosisKlotholncRNA-TUG1miRNA-223-3p

Identifiers

PMID38164143
PMCPMC10750200
OpenAlexW4389340229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.